Table 2.
Correlations between sPD-L1 and clinicopathological features in patients with metastatic colorectal cancer
| N | High N (%) | Low N (%) | p-value | |
|---|---|---|---|---|
| Gender | 0.735 | |||
| Male | 82 | 28 (46.34) | 44 (53.66) | |
| Female | 42 | 23 (54.76) | 19 (45.24) | |
| Age | 0.879 | |||
| ≤ 60 | 52 | 26 (50.00) | 26 (50.0) | |
| > 60 | 72 | 35 (48.61) | 37 (51.39) | |
| Metastasis | 0.347 | |||
| Synchronous | 111 | 53 (47.75) | 58 (52.25) | |
| Metachronous | 13 | 8 (61.54) | 5 (38.46) | |
| Location of primary | 0.187 | |||
| Right | 34 | 20 (58.82) | 14 (41.18) | |
| Left | 90 | 41 (45.56) | 49 (54.44) | |
| Numbers of metastatic sites | 0.080 | |||
| 1 | 92 | 41 (44.57) | 51 (55.43) | |
| ≥ 2 | 32 | 20 (62.50) | 12 (37.50) | |
| Liver metastasis | 0.809 | |||
| Yes | 80 | 40 (50.00) | 40 (50.00) | |
| No | 44 | 21 (47.73) | 23 (52.27) | |
| Lung metastasis | 0.809 | |||
| Yes | 29 | 13 (44.83) | 16 (55.17) | |
| No | 95 | 48 (50.53) | 47 (49.47) | |
| Peritoneum metastasis | 0.157 | |||
| Yes | 26 | 16 (61.54) | 10 (38.46) | |
| No | 98 | 45 (45.92) | 53 (54.08) | |
| Lymph node metastasis | 0.030 | |||
| Yes | 23 | 16 (69.57) | 7 (30.43) | |
| No | 101 | 45 (44.55) | 56 (55.45) |
Bold refers p < 0.05 with statistical significance
Bold italic refers p > 0.05 but < 0.10 with potentially statistical significance